Innovating Works

BREAKTHROUGH T1D

MELISSA: Mobile Artificial Intelligence Solution for Diabetes Adaptive Care BREAKTHROUGH T1D participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 The MELISSA project aims to provide a clinically validated, effective, trustworthy, and cost-efficient artificial intelligence (AI)-based di...
2022-05-23 - 2026-05-31 | Financiado
H2O: H2O Health Outcomes Observatory BREAKTHROUGH T1D participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage Patients' outcomes and experience of health care can be improved through the systematic capture and use of information from their perspectiv...
2020-09-30 - 2025-09-30 | Financiado
INNODIA HARVEST: Translational approaches to disease modifying therapy of type 1 diabetes HARVESTing the fruits of... BREAKTHROUGH T1D participó en un H2020: H2020-JTI-IMI2-2019-19-single-stage Building on the strong foundations of INNODIA, with its unique, Europe-wide clinical and basic research network for the study of type 1 diab...
2020-04-16 - 2024-04-30 | Financiado
imSAVAR: Immune Safety Avatar nonclinical mimicking of the immune system effects of immunomodulatory therapi... BREAKTHROUGH T1D participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The vision of Immune Safety Avatar (imSAVAR) is to develop a platform for integrated nonclinical assessments of immunomodulatory therapy saf...
2019-11-18 - 2025-11-30 | Financiado
BEAt-DKD: Biomarker Enterprise to Attack DKD Sofia ref. 115974 BREAKTHROUGH T1D participó en un H2020: H2020-JTI-IMI2-2015-05-two-stage Diabetic kidney disease (DKD) is the leading cause of end stage renal disease (ESRD), and its global incidence and prevalence have reached e...
2016-12-20 - 2023-08-31 | Financiado
INNODIA: Translational approaches to disease modifying therapy of type 1 diabetes an innovative approach tow... BREAKTHROUGH T1D participó en un H2020: H2020-JTI-IMI2-2014-01-two-stage Preclinical type 1 diabetes (T1D) research has made important advances in recent years, but less progress has been made in translating findi...
2015-12-07 - 2023-10-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.